General MedicationsINJECTIONStandard
TROGARZO
IBALIZUMAB-UIYK
Standard Dose
150MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview TROGARZO is listed in Drugs@FDA under application 761065 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient IBALIZUMAB-UIYK Form and strength INJECTABLE;INJECTION - 150MG/ML Sponsor THERATECHNOLOGIES Submission history Latest submission status date: 2023-12-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview TROGARZO is listed in Drugs@FDA under application 761065 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient IBALIZUMAB-UIYK Form and strength INJECTABLE;INJECTION - 150MG/ML Sponsor THERATECHNOLOGIES Submission history Latest submission status date: 2023-12-12 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.